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Summary
Skin dendritic cells (DCs) are thought to act as key
initiators of local T cell immunity. Here we show that
after skin infection with herpes simplex virus (HSV),
cytotoxic T lymphocyte (CTL) activation required
MHC class I-restricted presentation by nonmigratory
CD8+ DCs rather than skin-derived DCs. Despite a
lack of direct presentation by migratory DCs, blocking
their egress from infected skin substantially inhibited
class I-restricted presentation and HSV-specific CTL
responses. These results support the argument for ini-
tial transport of antigen by migrating DCs, followed by
its transfer to the lymphoid-resident DCs for presenta-
tion and CTL priming. Given that relatively robust CTL
responses were seen with small numbers of skin-
emigrant DCs, we propose that this inter-DC antigen
transfer functions to amplify presentation across a
larger network of lymphoid-resident DCs for efficient
T cell activation.
Introduction
Priming of virus-specific cytotoxic T lymphocyte (CTL)
responses after infection of the skin is thought to involve
the migration of localized dendritic cells (DCs) followed
by subsequent presentation of antigen within the drain-
ing lymph nodes (Banchereau and Steinman, 1998). The
prototypic skin DCs, the Langerhans cells, are found in
the outermost epidermal layer and have long been
thought to be directly involved in both antigen uptake
within infected skin as well as presentation for direct T
cell priming (Reis e Sousa et al., 1993; Romani et al.,
1989; Schuler and Steinman, 1985). Given this, it was
therefore surprising to find that CTL priming subsequent
to skin infection with herpes simplex virus (HSV) does
not appear to involve direct presentation of class
I-restricted antigen by Langerhans cells found within
the draining lymph nodes (Allan et al., 2003).
HSV infects both skin and mucosal epithelia. These
tissues are rich in Langerhans cells, leading to the
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edu.au (F.R.C.)reasonable assumption that they, or their progeny,
would directly present antigen for T cell priming. How-
ever, careful dissection of presentation after these infec-
tions excluded this type of presentation (Allan et al.,
2003; Zhao et al., 2003). In the case of CTL priming after
skin infection, presentation appeared to be dominated
by DCs expressing the CD8a homodimer (Allan et al.,
2003). These CD8 DCs represent a subset of DCs that
have no obvious precursor-product link with peripheral
tissue cells. They are sometimes termed ‘‘blood-
derived’’ DCs (Itano and Jenkins, 2003; Villadangos
and Heath, 2005) to distinguish them from cells that orig-
inate from immature tissue-derived DCs such as the epi-
dermal Langerhans cells and the dermal DCs. Given the
involvement of CD8 DCs in CTL priming after skin infec-
tion, it was proposed that either this subset was also
present in the skin and migrated with antigen, or an
alternative migratory DC population such as Langerhans
cells was involved in antigen transport from the site of
virus infection to the draining lymph nodes. In the latter
case, however, the trafficking DCs would not be directly
involved in priming. Here, we show that appearance of
skin-derived DCs in the draining lymph nodes, predom-
inantly of dermal rather than epidermal origin, was
intimately tied to the ability to prime a HSV-specific
CTL response after infection of the skin and that inhibit-
ing DC migration impaired this facet of antiviral immu-
nity. These results are consistent with a role for migra-
tory DCs in CTL priming despite their exclusion from
direct class I-restricted presentation.
Results
Only Lymph Node-Resident DCs Present Class
I-Restricted Antigen after Skin Infection with HSV
Skin painting with the dye fluorescein isothiocyanate
(FITC) is a simple and reliable means of identifying cuta-
neous-derived DCs within draining lymph nodes (Maca-
tonia et al., 1987). To this end, we applied FITC to flank
skin of C57BL/6 mice prior to infection with HSV. CD11c+
DCs were isolated from the brachial lymph nodes 24 hr
after infection and separated on the basis of surface ex-
pression of CD8 and FITC fluorescence into CD8+FITC2,
CD82FITC2, and CD82FITC+ (Figure 1). To examine pre-
sentation of viral antigen, these three populations were
then mixed with CFSE-labeled lymph node cells from
gBT-I mice, which express a TCR transgene specific for
the class I-restricted immunodominant determinant from
the HSV glycoprotein B (gB) (Mueller et al., 2002a).
Antigen presentation was then measured by T cell prolif-
eration, visualized as a progressive dilution of the CFSE
fluorescent marker (Lyons and Parish, 1994). Only the
CD8+ DCs efficiently stimulated the HSV-specific T cells
in the in vitro culture system (Figure 1). These cells did not
originate in the skin, as evident by their negative FITC
staining. In contrast, those DCs that were clearly FITC
positive lacked CD8 expression and did not present anti-
gen at detectable levels. These results reinforce our ear-
lier observation that class I-restricted presentation after
skin infection with HSV predominantly resides with the
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that these DCs are lymph node resident.
Arrival of Skin-Derived DCs Correlates with the
Capacity to Prime a HSV-Specific CTL Response
Previous work in our laboratory has shown that antigen
reaches the draining lymph nodes within hours of flank
skin inoculation with HSV (Mueller et al., 2002b; Stock
et al., 2004). This can be seen in experiments where
the inoculation site is removed at various times after in-
fection. Delaying such surgery for 8 hr after infection still
gives a robust CD8+ T cell response, albeit at levels less
than the maximum seen in control mice not subjected to
surgical intervention (Figure 2A). In contrast, T cell prim-
ing was absent if surgery was performed 2 hr after infec-
tion, showing that between 2 and 8 hr was required for
antigen to reach the draining lymph nodes for effective
CD8+ T cell priming. In an effort to determine whether
this timing corresponded to the arrival of skin-emigrant
DCs in the draining lymph nodes, the appearance of
FITC+ CD11c+ cells was determined at 2 and 8 hr after
infection. Near background percentages of skin-derived
DCs were present at 2 hr post infection as detected by
FITC labeling, whereas detectable migration was seen
at 8 hr (Figure 2B). This result is consistent with previous
reports showing the first arrival of skin-derived DCs be-
tween 3 and 8 hr after epicutaneous stimulation (Garg
et al., 2003; Macatonia et al., 1987; Salomon et al.,
1998). We calculate that just over 200 skin-derived
DCs have migrated into the draining brachial lymph
node within the first 8 hr after infection (Figure 2C).
Thus, T cell priming appears to correlate with the arrival
of skin-derived DCs into the draining lymph nodes, even
though these cells are not themselves responsible for
class I-restricted presentation of HSV antigen.
Figure 1. Lymph Node-Resident CD8+ DCs and Not Tissue-Derived
DCs Present Class I-Restricted Antigen after Skin Infection with HSV
C57BL/6 mice were painted on the flank skin with a 1% FITC solution
prepared in acetone 15 hr prior to inoculation with HSV by flank scar-
ification. 24 hr after infection, the draining brachial lymph nodes
were removed from 15 mice, pooled, and depleted of non-DCs.
CD11c+ DCs were sorted into CD8+FITC2 DCs, CD82FITC+ DCs,
and CD82FITC2 DCs. All sorted DC subsets were then cocultured
with CFSE-labeled gBT-I cells in vitro. After 60 hr of culture, gBT-I
T cells were analyzed for proliferation by flow cytometry. Data are
one representative of three independent experiments.Figure 2. Arrival of Skin-Derived DCs Correlates with the Capacity to
Prime a HSV-Specific CTL Response
(A) Between 2 and 8 hr is required for antigen to reach the draining
lymph nodes for effective CD8+ T cell priming. 1 3 105 gBT-I 3
B6.Ly5.1 lymph node cells were adoptively transferred into C57BL/
6 mice 1 day prior to inoculation with HSV by flank scarification. At
2 and 8 hr after infection, the inoculation site was surgically excised
or left intact (Intact). 7 days after infection, the proportion of splenic
CD8+ T cells of gBT-I origin was assessed by flow cytometry on the
basis of CD8 and CD45.1 expression. Shown is the percentage of
CD8+ T cells that are of gBT-I origin from three independent exper-
iments presented as mean 6 SEM. n, total number of mice per
experimental group. Significance was assessed with the Student’s
t test, and values are shown: ***p < 0.005.
(B) Skin-derived DCs arrive in the draining lymph nodes between
2 and 8 hr after HSV skin infection. C57BL/6 mice were painted on
the flank skin with a 1% FITC solution prepared in acetone 15 hr prior
to inoculation with HSV by flank scarification. 2 and 8 hr after infec-
tion, single-cell suspensions from two pooled draining brachial
lymph nodes were depleted of non-DCs, and the percentage of
CD11c+FITC+ DCs was determined by flow cytometry.
(C) The number of skin-derived DCs arriving in the draining lymph
node after HSV infection. Shown is the total number of CD11c+FITC+
DCs per lymph node from three independent experiments presented
as mean6 SEM. n, total number of mice per experimental group. To
obtain the total number of CD11c+FITC+ cells per lymph node, the
background CD11c+FITC+ cells obtained from mice painted with
FITC alone was subtracted from the total number of CD11c+FITC+
cells. Significance was assessed with the Student’s t test, and
values are shown: **p < 0.025.
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Distinct Waves of Skin DC Migration
(A) Kinetics of skin DC migration into the
draining lymph node after FITC painting.
C57BL/6 mice were shaved, depilated, and
painted with 12 ml of a 1% FITC solution pre-
pared in a solution of inflammatory stimulat-
ing mixture of acetone and dibutyl phthalate
(1:1, vol: vol) on the flank skin. At the times in-
dicated, single-cell suspensions from two
pooled draining brachial lymph nodes were
depleted of non-DCs, and CD11c+ DCs were
examined for CD205 and FITC expression
by flow cytometry. Shown is the percentage
of CD11c+FITC+ DCs in the lower right (der-
mal DC) and upper right (Langerhans cell)
quadrants. Data are one representative of
three independent experiments.
(B) The number of skin DCs arriving in the
draining lymph node after FITC painting.
The total number of CD11c+FITC+ DCs per
lymph node in the lower right (dermal DC) or
upper right (Langerhans cell) quadrants was
assessed by calculation as outlined in Exper-
imental Procedures. Data are one represen-
tative of three independent experiments pre-
sented as mean 6 SD.CTL Priming Can Be Seen in the Absence
of Any Direct Langerhans Cell Involvement
Langerhans cells have been reported to take at least
24 hr to reach draining lymph nodes after treatment of
the skin with various inflammatory stimuli. Thus, the cor-
relation between priming and a more rapid arrival of skin
DCs argued that these emigrants were unlikely to be
Langerhans cells. There are two major populations of
DCs in untreated skin that can be separated by expres-
sion of the marker CD205 (Henri et al., 2001; Kamath
et al., 2002). These are the strongly CD205-expressing
Langerhans cells (CD205hi) and the CD205 intermediate
dermal DCs (CD205int). Analysis of the brachial lymph
nodes after application on the skin of FITC dissolved in
the strong irritant dibutyl phthalate (known to rapidly
promote DC migration [Macatonia et al., 1987]) shows
that it takes more than 24 hr for CD205hi Langerhans
cells to reach the draining lymph nodes (Figure 3A).
Indeed, skin FITC+ DC migration can be seen in waves,
with the first appearance of dermal DCs peaking be-
tween 1 and 2 days after skin treatment followed by
a later, and more persistent, population of epidermal de-
rived Langerhans cells (Figure 3B).
The kinetics of skin DC subset migration, as deter-
mined by differential CD205 expression, largely mirrors
that described previously (Kissenpfennig et al., 2005)
with EGFP-CD207 (langerin) knockin mice to differen-
tially mark the individual skin DC subsets. We confirmed
the identity of these two subsets by using bone-marrow
replacement chimeras, taking advantage of the relativeradio-resistance of the Langerhans cell precursors
(Katz et al., 1979; Merad et al., 2002). It can be seen
that the majority of DCs isolated from the epidermis
are host-derived CD45.2 cells (Figure 4A) in CD45.1/
CD45.2 bone marrow irradiation chimeras, consistent
with the resistance of Langerhans cells to irradiation.
These host-derived (CD45.2+) cells are also found in
draining lymph nodes and appear FITC positive at 96
hr but not 24 hr after initiation of skin inflammation
(Figure 4B), reinforcing that Langerhans cells take longer
than 24 hr to arrive in draining lymph nodes after appli-
cation of an inflammatory stimulus. The FITC+ cells
found in draining lymph nodes at 24 hr posttreatment
are all donor derived, confirming that the dermal DCs
are replaced during irradiation and bone-marrow recon-
stitution (Figure 4B). These cells are clearly CD205int, in
contrast to the host-derived Langerhans cells present
96 hr after treatment, which are CD205hi (Figure 4C).
Thus, differential expression of this latter marker is a rea-
sonable means of discriminating between the different
skin DC populations. By using CD205 staining, we found
that whereas the initiation of T cell priming correlated
with the arrival of DCs from infected skin, these early
times were biased toward the ‘‘first wave’’ of skin emi-
grant DCs, which are of dermal rather than epidermal or-
igin. 8 hr after infection, the majority of the FITC-bearing
cells are predominantly CD205int dermal DCs, distinct
from the FITC+ CD205hi Langerhans cells seen 96 hr
after inoculation (Figure 4D). Finally, we confirmed the
kinetics of Langerhans cell entry into skin-draining
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beling of DCs with the antibody against the Langerhans
cell-specific marker, langerin. We found that FITC+ lan-
gerin+ cells made up a substantial proportion of FITC+
DCs in the draining lymph node 96 hr after sensitisation
Figure 4. Confirmation of Skin DC Identity by Bone Marrow
Replacement Chimeras
(A) Langerhans cells remain host derived in bone marrow replace-
ment chimeras. Epidermal sheets isolated from CD45.1/CD45.2
bone marrow chimeric mice were cultured for 48 hr in medium con-
taining 6Ckine. Cells migrating into the medium were collected in
separate 24 hr pools and combined for analysis. Gates were gener-
ated on CD11c+CD205+ Langerhans cells, and these cells were ana-
lyzed for expression of CD45.2. The percentage of CD11c+CD205+
cells that are CD45.2+ is shown in the right histogram.
(B) Skin inflammation causes the initial migration of donor-derived
dermal DC into the draining lymph node followed by a second
wave of host-derived Langerhans cells. CD45.1/CD45.2 bone-
marrow chimeric mice were painted with 12 ml of a 1% FITC solution
prepared in acetone:dibutyl phthalate (1:1, vol:vol) on the flank skin.
24 and 96 hr later, single-cell suspensions from two pooled draining
brachial lymph nodes were depleted of non-DCs, and CD11c+ DCs
were examined for CD45.2 and FITC expression by flow cytometry.
(C) Donor-derived dermal DCs are CD205int and host-derived Lang-
erhans cells are CD205hi in the draining lymph node. CD205 expres-
sion was analyzed on gated populations of FITC+CD45.22 DCs
obtained 24 hr after treatment (dark line) and FITC+CD45.2+ DCs
obtained 96 hr after treatment (gray shaded). CD205 expression
was also analyzed on non-CD11c+ cells (dotted line). Data are one
representative of three independent experiments.
(D) Skin infection with HSV results in an initial wave of dermal DC mi-
gration into the draining lymph node followed by a second wave of
Langerhans cells. C57BL/6 mice were painted on the flank skin
with a 1% FITC solution prepared in acetone 15 hr before inoculation
with HSV by flank scarification. 8 and 96 hr after infection, single-cell
suspensions from two pooled draining brachial lymph nodes were
depleted of non-DCs, and CD11c+ DCs were examined for the
expression of CD205 and FITC by flow cytometry. Data are one rep-
resentative of three independent experiments.but made only a minimal contribution 24 hr after skin
treatment (see Figure S1 in the Supplemental Data avail-
able with this article online).
As a consequence of this delayed migration, one
could argue that the Langerhans cell contribution to an-
tigen presentation would only become evident at least 3
days after infection. To show that this was not the case,
we examined the relative antigen presentation contribu-
tion of CD8-negative DCs for 11 days after flank infec-
tion, because this subset includes Langerhans cells
as well as other DCs of skin origin. Whole lymph node
cell digests from HSV-infected mice, treated with
anti-CD11c or anti-CD8, were used to stimulate a lacZ-
inducible HSV-specific T cell hybridoma (Mueller et al.,
2002b). The depletion with these antibodies inhibited
T cell activation, arguing for a dominant CD8+ DC contri-
bution to class I-restricted presentation from day 3 to
day 11 after infection (Figure 5). Finally, quantitative
PCR on different DC subsets (purified on the basis of
CD205 and CD8 expression) showed minimal virus DNA
content across days 1 to 4 after infection in the skin-
draining lymph nodes, with values of less than 12 total
copies in each subset within a given lymph node (Fig-
ure S2). These amounts of viral DNA argue against the
contribution of DC infection to direct presentation but
still leave open the possibility that it may nonetheless
be involved in antigen transfer.
HSV-Specific CD8+ T Cells Are Crossprimed
after Flank Skin Infection
CD8+ DC appear to possess a relatively unique ability to
crosspresent exogenous, cell-associated antigen (den
Haan et al., 2000). In order to determine the importance
of crosspresentation in this model of HSV-specific T cell
priming, we took advantage of our recent observation
that engagement of toll-like receptors (TLRs) via CpG
causes CD8+ DC maturation that inhibits crosspresenta-
tion of subsequently encountered antigens (Wilson
et al., 2006). The CpG-mediated block is transient, dis-
appearing well before cessation of viral replication
under normal circumstances (van Lint et al., 2004;
Figure 5. Dominant CD8+ DC Contribution to Class I-Restricted Pre-
sentation during Cutaneous HSV Infection
C57BL/6 mice were inoculated with HSV by flank scarification. At dif-
ferent days after infection, the draining brachial lymph nodes were
removed from 8 mice and pooled, and single-cell suspensions
were either nondepleted or depleted of CD11c+ or CD8+ cells. De-
pleted preparations were then used to stimulate a lacZ-inducible
HSV-specific T cell hybridoma. Shown is the total number of lacZ-
positive cells per lymph node from two independent experiments
presented as mean 6 SEM with n = 6 for each time examined.
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tion was used in conjunction with excision of the primary
inoculation site to assess the contribution of crosspre-
sentation in T cell priming. Such surgical intervention
limits the spread of virus as well as abbreviating the
infection while maintaining robust CD8+ T cell priming
(Stock et al., 2004). Pretreatment of C57BL/6 animals
with CpG prior to flank infection inhibits the expansion
of adoptively transferred gBT-I T cells measured 7
days after virus infection (Figure 6A). This inhibition
does not appear to be a consequence of the abolition
of skin-resident DC migration, because CpG treatment
results in only minor changes in FITC+ DC accumulation
after skin labeling (Figure 6B), which were statistically
insignificant. Therefore, the results indicate that the
mechanism underlying the CD8+ DC involvement in
T cell priming after skin infection with this virus is tied
to the crosspresentation capability of this particular
population.
HSV-Specific CTL Priming Can Be Inhibited
by Blocking Skin-DC Migration
Given that CTL priming appeared to be tied to DC migra-
tion, we reasoned that these cells might traffic antigen to
the draining lymph nodes even though they themselves
are not directly involved in class I-restricted presenta-
tion. If this were the case, then blocking egress of DC
from the skin should inhibit class I-restricted presenta-
tion in the draining lymph nodes. To this end, we took
advantage of the synthetic prostaglandin analog,
BW245C, known to inhibit skin DC migration (Angeli
et al., 2001). Intradermal administration of BW245C
blocks migration of FITC+ DCs into draining lymph no-
des after infection with HSV (Figure 7A). BW245C does
not alter DC migration when applied to a site adjacent
to that labeled with FITC, confirming that the block in
migration is not a consequence of an indirect systemic
effect by this agent.
We next determined whether skin DC egress was nec-
essary for class I-restricted presentation within the
draining lymph nodes. To show this, mice were treated
with BW245C prior to HSV infection, and 2 days later
these animals received CFSE-labeled gBT-I cells. Prolif-
eration of the transferred T cells was examined 60 hr
later in draining brachial lymph nodes in infected mice
treated with the prostaglandin analog or vehicle control.
Treatment inhibited antigen-specific proliferation of
gBT-I cells by more than 75% in terms of overall prolifer-
ating cell numbers (Figure 7B). Thus, class I-restricted
antigen presentation depended heavily on trafficking
of DCs from infected skin to the draining, brachial lymph
nodes. Furthermore, inhibition of presentation was
mirrored by decreased CD8+ T cell expansion as a con-
sequence of BW245C treatment (Figure 7C). For these
experiments, mice were flank-inoculated and the area
of skin containing the inoculation site was surgically
excised 8 hr later. Treatment with BW245C at the site
of inoculation inhibited T cell expansion in these exper-
iments, but had no effect when the site of treatment and
inoculation were at separate locations on the mouse
flank (Figure 7C). Thus, inhibition of CTL priming results
from modification of the local skin environment by
BW245C and not from any wider inhibitory effect of
this drug.To further show that alteration of DC migration affects
T cell expansion, we pretreated the flank of mice with the
contact-sensitizing agent dinitrofluorobenzene (DNFB),
which causes transient mobilization of skin DCs. This
limits subsequent DC migration (Figure 7D; Bacci
et al., 1997). Infection during this period of limited migra-
tion inhibits the level of subsequent HSV-specific T cell
expansion (Figure 7E). The combined evidence of inhibi-
tion of presentation and T cell expansion argue that
CD8+ T cell immunity is severely compromised in the ab-
sence of DC egress from the skin, consistent with the
skin-derived DCs playing a ferrying role independent
of actual presentation.
Figure 6. HSV-Specific CD8+ T Cells Are Crossprimed after Cutane-
ous HSV Infection
(A) Impairment of crosspresentation by pretreatment with CpG re-
sults in the abolition of HSV-specific CD8+ T cell priming. 1 3 105
gBT-I 3 B6.Ly5.1 lymph node cells were adoptively transferred
into C57BL/6 mice 1 day before intravenous injection with 20 nmol
of CpG. 18 hr later, mice were inoculated with HSV by flank scarifica-
tion. 8 hr after infection, all animals had their inoculation site surgi-
cally removed. After 7 days, the proportion of splenic CD8+ T cells
of gBT-I origin was assessed by flow cytometry on the basis of
CD8 and CD45.1 expression. Shown is the percentage of CD8+ T
cells that are of gBT-I origin from three independent experiments
presented as mean6 SEM. n, total number of mice per experimental
group. Student’s t test and values are shown: **p < 0.01.
(B) Skin DC migration is not impaired in CpG-treated mice. C57BL/6
mice were injected intravenously with 20 nmol of CpG. 18 hr later,
mice were painted with 12 ml of a 1% FITC solution prepared in ace-
tone:dibutyl phthalate (1:1, vol:vol) on the flank skin. 24 hr after
painting, single-cell suspensions from two pooled draining brachial
lymph nodes were depleted of non-DCs and the percentage of
CD11c+FITC+ DCs was determined by flow cytometry. Shown is
the total number of CD11c+FITC+ DCs per lymph node from two
independent experiments presented as mean 6 SEM. n, total num-
ber of mice per experimental group. The total number of
CD11c+FITC+ cells was determined as in Figure 2C. Student’s t
test and values are shown: n.s, not significant.
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(A) A prostaglandin D2 analog blocks skin DC appearance in the skin-draining lymph node. C57BL/6 mice were painted on the flank skin with
a 1% FITC solution prepared in acetone. 15 hr later, mice were treated with 20 ml of BW245C (100 nM) or vehicle intradermally on or adjacent
to the FITC-painted flank skin and inoculated with HSV by flank scarification on the FITC-treated area. 24 hr after infection, single-cell suspen-
sions from two pooled draining brachial lymph nodes were depleted of non-DCs and the percentage of CD11c+FITC+ DCs was determined by
flow cytometry. Shown is the total number of CD11c+FITC+ DCs per lymph node from three independent experiments presented as mean6 SEM.
n, total number of mice per experimental group. Significance was assessed by the Student’s t test and values are shown: **p < 0.01. The total
number of CD11c+FITC+ cells was determined as in Figure 2C.
(B) Skin DC egress is necessary for MHC class I-restricted presentation within the draining lymph node. C57BL/6 mice were treated with BW245C
(100 nM) or vehicle intradermally and inoculated with HSV by flank scarification on the treated area (as described in the Experimental Proce-
dures). 8 hr after infection, all animals had their inoculation site surgically removed. 2 days after infection, all mice were injected intravenously
with 13 106 CFSE-labeled gBT-I3 B6.Ly5.1 lymph node cells. 60 hr later, the draining brachial lymph node was removed and the CD8+CD45.1+
cells were examined for CFSE dilution. Shown is the total number of dividing gBT-I cells per lymph node from three independent experiments
presented as mean 6 SEM. n, total number of mice per experimental group. Significance was assessed by the Student’s t test and values are
shown: **p < 0.01.
(C) Skin DC egress is necessary for the expansion of HSV-specific CTL in vivo. C57BL/6 mice were injected intravenously with 1 3 105 gBT-I 3
B6.Ly5.1 lymph node cells. 1 day later, mice were treated with BW245C or vehicle and infected on the treated area (Vehicle, BW245C) or adjacent
to it (Adjacent) with HSV by flank scarification as described in the Experimental Procedures. 8 hr after infection, all animals had their inoculation
site surgically removed. 7 days after infection, the proportion of splenic CD8+ T cells of gBT-I origin was assessed by flow cytometry on the basis
of CD45.1 and CD8 expression. Shown is the percentage of CD8+ T cells that are of gBT-I origin from four independent experiments presented as
mean6 SEM. n, total number of mice per experimental group. Statistical significance was assessed by the Student’s t test and values are shown:
***p < 0.005.
(D) Epicutaneous application of DNFB inhibits skin DC egress. C57BL/6 mice were shaved, depilated, and painted on the flank skin with a 0.5%
DNFB solution prepared in acetone. 12 hr later, treated full-thickness skin was removed and cultured for 48 hr in medium containing 6Ckine. Cells
migrating into the medium were collected in separate 24 hr pools and combined for analysis. Gates were generated on CD11c+I-Ab+ DCs. Shown
is the total number of emigrant DCs obtained from two independent experiments presented as mean6 SEM. n, total number of mice per exper-
imental group.
(E) Pretreatment with DNFB inhibits HSV-specific CTL expansion. C57BL/6 mice were injected intravenously with 13 105 gBT-I3B6.Ly5.1 lymph
node cells. 1 day later, mice were treated with DNFB or vehicle on the flank skin. 12 hr later, mice were infected on the treated area (Vehicle,
DNFB) or adjacent to it (Adjacent) with HSV by flank scarification. 8 hr after infection, all animals had their inoculation site surgically removed.
7 days after infection, the proportion of splenic CD8+ T cells of gBT-I origin was assessed by flow cytometry on the basis of CD45.1 and CD8
expression. Shown is the percentage of CD8+ T cells that are of gBT-I origin from three independent experiments presented as mean 6 SEM.
n, total number of mice per experimental group. Statistical significance was assessed by the Student’s t test and values are shown: **p < 0.01.
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The results presented here build on our previous report
showing that Langerhans cells are not involved in direct
class I-restricted presentation after HSV infection of the
skin (Allan et al., 2003). In that study, Langerhans cells
were formally excluded from playing any direct role in
CTL priming after HSV infection with bone-marrow re-
placement chimeras where they survive irradiation.
Here, we address the role of the other major subset of
DCs originating in the skin, the dermal DCs, and show
that these also have little involvement in class
I-restricted presentation. Overall, this study highlights
the previously observed dominance of the nonmigrat-
ing, lymph node-resident CD8+ DCs subset in CTL prim-
ing in this virus infection (Belz et al., 2004a; Smith et al.,
2003).
Despite this, the egress of DCs from skin appears in-
timately tied with CTL priming. Priming capacity within
lymph nodes required the arrival of skin-derived DCs,
and inhibition of this migration severely compromised
the ensuing class I-restricted presentation and CD8+ T
cell expansion. From these data, it can be concluded
that skin DC act as transporters, and once within the
draining lymph nodes donate their antigenic cargo to
the resident CD8+ DC subset critical to effective presen-
tation. Moreover, such transfer explains the dominant
role of the CD8+ DCs in this response, since these cells
have a unique ability to crosspresent cell-derived exog-
enous antigen (den Haan et al., 2000), and crosspresen-
tation is shown here and elsewhere (Orr et al., 2005) to
be important in this event.
Formal proof of inter-DC antigen transfer was found in
another form of localized infection, namely respiratory
infection with influenza virus (Belz et al., 2004b). There,
transfer was successfully demonstrated in vitro be-
tween lung-derived DCs and the presenting CD8+ DC
population. Attempts at reproducing this in the case of
skin infection have so far proven futile, even when we
resorted to using purified FITC+ DCs as the potential
antigen donors in our in vitro culture system (data not
shown). This failure could reflect differences between
the respective viruses, the progression of each infec-
tion, or unique features of the migrating DC populations
originating in lung and skin.
A proposal for inter-DC antigen transfer is not without
precedent, having been suggested in a number of ex-
perimental settings (Belz et al., 2004b; Fleeton et al.,
2004; Inaba et al., 1998; Kleindienst and Brocker, 2003;
Norbury et al., 2002; Scheinecker et al., 2002; Turley
et al., 2003). Most definitively, Inaba et al. (1998) formally
showed class II-restricted antigen transfer between
migrating DCs and a separate subset within the T cell
zones, an area associated with the CD8+ DCs (De Smedt
et al., 1996; Pulendran et al., 1997). Strikingly, this was
found to be highly efficient, spreading relatively small
amounts of input antigen over a large proportion of the
lymphoid-resident DC population. Indeed, it has been
argued that this is the role of inter-DC transfer, to in-
crease priming efficiency by spreading antigen over
the wider DC pool (Lindquist et al., 2004). This efficiency
could explain the extreme potency of the migrating cells
highlighted by our results. Skin infection with HSV re-
sults in very rapid class I-restricted presentation withinthe draining lymph nodes (Mueller et al., 2002b). Even in-
fection times as short as 8 hr resulted in robust levels of
CTL expansion (Figure 2A). FITC labeling showed that
only a few hundred skin-derived DCs would have
made their way to the draining brachial lymph node by
the time infection was stopped by surgical intervention,
and yet these few cells provide prolonged presentation
and robust levels of CTL expansion (Stock et al., 2004).
Mechanisms for inter-DC antigen transfer remain un-
clear at this time. Amigorena and colleagues have pro-
posed that exosomes released by migrating DC could
serve as antigen spreaders within the lymph nodes
(Thery et al., 2002). Others have argued that such trans-
fer occurs within the context of DC apoptosis and pro-
vided evidence for transfer of apoptotic bodies (Fleeton
et al., 2004; Inaba et al., 1998). While this is attractive,
given that HSV infection has been linked with rapid DC
apoptosis (Jones et al., 2003) and transfer of antigen
from dying cells would be consistent with the impor-
tance of crosspresentation in this process (Albert
et al., 1998), it remains to be shown that transfer truly re-
quires cell death in this situation. Lindquist et al. (2004)
have provided dramatic evidence that newly migrating
DCs probe the lymphoid-resident DC network, arguing
that this could facilitate antigen spreading. Such exten-
sive probing, however, is difficult to reconcile with a pop-
ulation of incoming cells reported to be functionally
compromised by HSV infection (Mikloska et al., 2001;
Salio et al., 1999) and marked for rapid cell death (Bosn-
jak et al., 2005). Clearly, further work is required to clarify
this issue.
Possibly one of the most challenging aspects of a pro-
posal for inter-DC antigen transfer is the spatial separa-
tion between peripheral infection and effective T cell
priming in the lymph nodes. In the context of localized
infection, the priming lymphoid environment is removed
from the site of virus infection with its potential for direct
DC maturation through virus binding to elements like the
toll-like receptors (Sato and Iwasaki, 2004; Sporri and
Reis e Sousa, 2005). Indeed, many of the discussions
of antigen transfer between migratory and lymphoid-
resident DC populations have been couched in terms
of steady-state presentation and T cell tolerance (Inaba
et al., 1998; Steinman and Nussenzweig, 2002). Along
these lines, it is easy to envisage CTL priming in the tra-
ditional setting where tissue DCs migrate as a conse-
quence of contact with the pathogen and this is then fol-
lowed by presentation within the draining lymph nodes
by these same cells, now mature as a consequence of
pathogen encounter at the site of infection. However,
DCs can be activated by other mechanisms. Helper
T cells can stimulate DCs through CD40 and license
them for CTL priming (Bennett et al., 1998; Ridge et al.,
1998; Schoenberger et al., 1998). Primary HSV-specific
CTL expansion is highly helper T cell dependent (Jen-
nings et al., 1991), and we have shown that CD4+ T cells
rapidly license the CD8 DCs after infection (Smith et al.,
2004). Migrating antigen-bearing DCs could therefore
activate virus-specific helper T cells, which could in turn
license the lymph node-resident CD8 DCs. Consistent
with this scenario, the mucosal equivalent of the dermal
DCs implicated here in antigen transport after skin infec-
tion are known to present class II-restricted antigen after
mucosal infection with HSV (Zhao et al., 2003).
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160Overall, our experiments highlight that a simple model
where the same DCs migrate and then present antigen is
inadequate in the case of skin infection with HSV. While
inter-DC transfer of antigen has been formally proposed
in other infections (Belz et al., 2004b; Fleeton et al.,
2004), its relative contribution has been unclear in the
face of presentation by the migrating DC population.
Here, the tissue-derived DCs appear to make little con-
tribution to CD8+ T cell priming for reasons unknown.
Yet HSV-specific CTL priming as a consequence of
skin scarification is extremely rapid and efficient. There-
fore, these studies argue that transfer of antigen be-
tween migrating DCs to a wider lymph node-resident
CD8 DC population provides a powerful means for effec-
tive CTL priming.
Experimental Procedures
Mice and Virus
C57BL/6, B6.SJL-PtprcaPep3b/BoyJ (B6.Ly5.1), and gBT-I.1 3
B6.Ly5.1 were obtained from the Department of Microbiology and
Immunology (University of Melbourne). gBT-I.1 (H-2b) transgenic
mice (gBT-I) express a TCR (Va2Vb8.1) specific for the immunodo-
minant epitope of HSV gB (gB498-505) (Mueller et al., 2002a). Mice
were housed in SPF conditions and all experimentation was
conducted according to institutional ethical guidelines. The KOS
strain of herpes simplex 1 virus (HSV) was propagated and titred
with VERO cells grown in Minimal Essential Medium containing
10% FCS.
Virus Inoculations and Inoculation Site Excision
Mice were inoculated with 13 106 plaque forming units of HSV-KOS
via the flank scarification model of HSV infection as previously de-
scribed (van Lint et al., 2004). In some experiments (Figures 2A,
6B, 7B, 7C, and 7E), the infection site was surgically excised 2 or 8
hr after flank inoculation as described elsewhere (Stock et al.,
2004). Briefly, a 0.53 0.5 cm area of full-thickness skin encompass-
ing the infection site was excised from anaesthetized mice. The
wound was closed with 9 mm surgical wound clips (BD Biosciences).
Generation of Bone Marrow Chimeras
Chimeric mice were generated by irradiation of recipient C57BL/6
mice (CD45.2+) with two doses of 550 cGray, 4 hr apart. 5 3 106
B6.Ly5.1 (CD45.1+) bone marrow cells were injected intravenously.
The mice were allowed to reconstitute for 8 weeks before use.
Fluorescein Isothiocyanate Painting
Mice were anesthetized, shaved, and depilated by means of Veet
(Reckitt Benckiser, Swindon, UK) as previously described (van Lint
et al., 2004). For experiments involving HSV infection, mice were
painted on the posterior flank, lateral to the spine and over the
spleen with 12 ml of a 1% FITC solution (Isomer 1, Sigma-Aldrich,
St. Louis, MO) prepared in acetone prior to infection. 15 hr later,
mice were infected with HSV on the painted region via the scarifica-
tion method. For experiments involving the tracking of skin DC into
the lymph node after skin irritation, C57BL/6 and chimeric mice were
shaved and depilated as described above. Mice were then painted
with 12 ml of a 1% FITC solution prepared in acetone:dibutyl phtha-
late (1:1, vol/vol; Sigma-Aldrich) as previously described (Macatonia
et al., 1987).
Dendritic Cell Isolation from Lymph Nodes
The ipsilateral brachial lymph node draining the site of skin treat-
ment was removed. The lymph nodes were cut into small fragments
and digested in collagenase type II (1 mg/ml [Worthington Biochem-
icals, Lakewood, NJ]) and DNase (1 mg/ml grade II bovine pancreatic
DNase [Boehringer-Mannheim, Mannheim, Germany]) and then de-
pleted of plasmacytoid DCs (CD19+) and non-DC populations with
antibody and magnetic beads as previously described (Belz et al.,
2004a). In brief, single-cell suspensions were incubated for 30 min
with predetermined optimal concentrations of purified antibodies:anti-CD3 (KT3), anti-Thy1 (T24/31.7), anti-CD19 (ID3), and anti-eryth-
rocyte (TER-119) prior to the removal of antibody bound cells with
anti-rat Ig-coupled magnetic beads (Dynabeads; Dynal, Oslo, Nor-
way). For sorting of DCs into subsets (Figure 1), purified lymph
node DCs were labeled with CD11c-PE (HL3; BD PharMingen, CA)
and CD8a-APC (53-6.7; BD PharMingen) and sorted by FACS (MoFlo
instrument, Cytomation, Fort Collins, CO).
DCs isolated from the draining brachial lymph node of C57BL/6
mice (Figures 2B, 2C, and 3) were stained for CD8a-APC (53-6.7),
CD205-PE (NLDC-145), and CD11c-biotin (HL3; BD PharMingen),
followed by streptavidin-PerCp (BD PharMingen). Prior to langerin
staining (Figure S1), a 30 min CD16/32 blocking step with the
2.4G2 supernatant was performed. Cell-surface langerin staining
was carried out by incubation with unconjugated mouse anti-
langerin (205C1; AbCys, Paris, France). Antibody bound cells were
detected with anti-mouse IgMa-PE (AF6-78; BD PharMingen). DCs
isolated from the lymph nodes of chimeric mice (Figures 4B and
4C) were stained for CD205-PE (NLDC-145), CD45.2-PerCp (104;
BD PharMingen), and CD11c-biotin (HL3) and then with strepta-
vidin-APC (BD PharMingen). Analyses were performed with a FACS-
Calibur flow cytometer (Becton Dickinson, San Jose, CA).
Quantifying Skin DC Migration into the Lymph Node
To calculate the total number of CD11c+FITC+ DCs per lymph node
(Figures 2C, 3B, 6B, and 7A), the total number of lymph node cells
(after DC enrichment) was multiplied by the percentage of
CD11c+FITC+ cells obtained by flow cytometry. To calculate the total
number of FITC+ dermal DCs and Langerhans cells per lymph node
in Figure 3B, the total number of lymph node cells (after enrichment)
was multiplied by the percentage of CD11c+FITC+ in lower right (der-
mal DC) or upper right (Langerhans cell) quadrants. In experiments
involving FITC application prior to HSV infection (Figures 2C and
7A), the background CD11c+FITC+ cells obtained from mice painted
with FITC alone was subtracted from the total number of
CD11c+FITC+ cells.
Naive CD8+ T Cell Stimulation by Dendritic Cells In Vitro
The gBT-I 3 B6.Ly5.1 CD8+ T cells were purified by antibody and
magnetic bead depletion of lymph node cells and were labeled
with 2.5 mM CFSE (Sigma-Aldrich) as previously described (Allan
et al., 2003). 2 3 104 purified DCs were cocultured in vitro with 5 3
104 CFSE-labeled gBT-I cells in 200 ml RPMI containing 10% FCS
in V-bottom, 96-well tissue culture plates (Costar, Corning Incorpo-
rated, NY). Proliferation was measured as the loss of CFSE fluores-
cence as determined by flow cytometry at 60 hr of culture. Cells
were stained with anti-CD8a-APC and anti-CD45.1-PE (A20; BD
PharMingen). Dead cells were excluded with propidium iodide (PI;
Sigma-Aldrich) staining. CD8a+CD45.1+PI2 cells were analyzed for
proliferation by a FACSCalibur flow cytometer.
In Vivo gBT-I Stimulation
Lymph nodes from gBT-I 3 B6.Ly5.1 mice were harvested, made
into single-cell suspensions, and labeled with CFSE as described
above. 1 3 106 CFSE-labeled lymphocytes were adoptively trans-
ferred via i.v. tail vein injection 2 days after infection. 60 hr after
transfer, the ipsilateral draining brachial lymph node was harvested
and stained with anti-CD8a-APC (53-6.7) and CD45.1-PE (A20),
and CD8a+CD45.1+PI2 cells were analyzed for proliferation by a
FACSCalibur flow cytometer.
In Vivo gBT-I Population Expansion Assays
C57BL/6 mice received 1 3 105 gBT-I 3 B6.Ly5.1 lymph node
cells 1 day prior to flank HSV inoculation. 7 days after infection,
mice were sacrificed and their spleens removed. Single-cell suspen-
sions were stained with anti-CD8a-APC (53-6.7) and CD45.1-PE
(A20). CD8a+CD45.1+PI2 cells were analyzed for expansion by a
FACSCalibur flow cytometer.
Prostaglandin D2, Methylated Oligonucleotide,
and 2,4-Dinitrofluorobenzene Treatments
For prostaglandin treatment, mice were shaved and depilated as
described above. 20 ml of the prostaglandin D2 analog, BW245C
(100 nM; Cayman Chemical, MI) or DMSO (vehicle control) was in-
jected intradermally into a 0.53 0.5 cm area of skin on the posterior
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161flank. After 20 min, mice were inoculated with HSV by scarification
either on, or adjacent to, the BW245C-treated region. Where indi-
cated, the oligonucleotide CpG was administered by the intra-
venous injection of 20 nmol of synthetic phosphorothioated
CpG1668 (Geneworks, SA, Australia) dissolved in PBS 18 hr prior
to inoculation with HSV. For 2,4-dinitrofluorobenzene (DNFB) treat-
ment, mice were shaved and depilated prior to the application of
25 ml of 0.5% DNFB (Sigma-Aldrich) or acetone (vehicle) to the
skin on the posterior flank, 12 hr prior to inoculation with HSV either
on, or adjacent to, the DNFB-treated region.
Dendritic Cell Isolation from Skin Biopsies
Epidermal dendritic cells were isolated from epidermal sheets by
culture in the presence of 6Ckine (R&D Systems, MN) as described
previously (Allan et al., 2003). The DCs isolated from epidermal
sheets of chimeric mice were stained with CD11c-biotin (HL3),
CD205-PE (NLDC-145), and CD45.2-FITC (104; BD PharMingen)
and then with streptavidin-APC. Analyses were performed with
a FACSCalibur flow cytometer. To assess DC emigration after
DNFB application, full-thickness skin was excised, removed of sub-
cutaneous tissue by blunt dissection, and cultured in the presence
of 6Ckine as previously described (Allan et al., 2003). Isolated cells
were stained with CD11c-biotin (HL3) and I-Ab-PE (AF6-120.1) and
then with streptavidin-APC prior to flow cytometric analysis. The to-
tal number of emigrant DCs was calculated by adding 2 3 104 BD
PharMingen Sphero Blank calibration particles (San Diego, CA) to
each sample and collecting 1 3 104 beads during analysis.
Depletion of Cell Subsets and the Detection of Lymph Node
Antigen Presentation with lacZ-Inducible Hybridomas
The draining brachial lymph node was removed from HSV flank-
inoculated mice at different times after infection. The lymph nodes
were cut into small fragments and digested in collagenase type II
(1 mg/ml [Worthington Biochemicals]) and DNase (1 mg/ml grade II
bovine pancreatic DNase [Boehringer-Mannheim]) to form a sin-
gle-cell suspension. Cells were then incubated with either N418
(anti-CD11c) or 53-6.7 (anti-CD8a) for 30 min at 4C. After washing,
the cells were then incubated with sheep anti-rat IgG-coupled
magnetic beads (Dynabeads M-450; Dynal Biotech, Oslo, Norway),
and bead bound cells were removed with a magnet as previously
described (Belz et al., 2002).
The lacZ-inducible gB-specific hybridoma HSV-2.3.E2 was cloned
and maintained as previously described (Belz et al., 2002; Mueller
et al., 2002b). For the detection of antigen presentation, brachial
lymph nodes from HSV-infected mice were made into single-cell
suspensions, and 2-fold serial dilutions of the CD11c-depleted,
CD8-depleted, or nondepleted fractions were prepared in a flat-
bottom, 96-well plate beginning at 106 cells/well. Hybridoma cells
(105) were added to each well before overnight culture. Background
lacZ expression was determined with hybridoma cells cultured in the
equivalent cell fractions obtained from naive mice, while the positive
expression was measured by hybridoma incubation with the
gB498-505 peptide. Detection of activation with X-gal was performed
on the cultures as previously described (Belz et al., 2002). Cultures
were examined microscopically for the presence of blue cells 12–
15 hr after incubation at 37C. The total number of lacZ-positive cells
per lymph node was calculated by subtracting the background ex-
pression and then multiplying the number of blue events obtained
in a well by the total number of cells in the entire lymph node
(obtained by standard trypan blue exclusion).
Quantification of HSV Genomic DNA in DC Subsets
by Real-Time PCR
Real-time PCR of viral DNA in purified DC subsets was performed as
previously described (Wilson et al., 2006).
Statistical Analysis
Normally distributed data was compared by the two-tailed Student’s
t test, with a p value of <0.05 considered significant. Data are pre-
sented as mean 6 standard error (SEM).
Supplemental Data
Two Supplemental Figures can be found with this article online at
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